Why publish a range at all?

Private patients need a cost anchor before entering a consultation pathway. TreatCompare publishes aggregated editorial ranges so readers can understand likely order of magnitude without being directed to a specific supplier or encouraged to choose a medicine by price.

Is this a buying guide?

No. Supplier names, rankings, discounts and buy links are not shown. HRT medicines can only be supplied after a UK-registered prescriber assesses suitability.

What does the range include?

The range reflects observed provider-published medicine supply records where available. Consultation, monitoring, delivery and prescription issue fees may be separate unless a provider explicitly bundled them in the source record.

Editorial market data

UK private HRT prescription price ranges

Name: UK Private HRT Price Ranges 2026
Creator: TreatCompare
Published: 2026-05-18
License: https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/
Keywords: private HRT cost range, menopause clinic price data, prescription medicine market reporting, healthcare price transparency

Aggregated editorial context from observed provider-published UK private HRT prescription medicine price records. Supplier names are not shown. This is not an advert, recommendation, buying guide, offer of sale or medical advice.

Latest observed record: 2026-05-18. Ranges are shown alphabetically, not ranked by price.

Observed records

Source providers

Medicine labels

Supplier names shown

Compliance and reader-use framing

These bands are published because readers need an approximate cost anchor before deciding whether to enter a private assessment pathway. They must not be read as a recommendation to request, choose or buy any prescription-only medicine. Suitability is a clinical decision for a UK-registered prescriber after assessment.

Observed aggregated ranges

Medicine label	Monthly-equivalent range	Observed source-price range	Basis	Records	Source providers	Latest source date

Supplier names and source URLs are withheld from the public table to avoid creating a provider-by-medicine buying surface. Source records are retained internally for audit.

Consumer-safe service page

The consumer route remains service-level: menopause consultation costs, prescription fees, dispensing route, monitoring and NHS/private route questions.

View private HRT service-cost information

Sources & further reading

MHRA Blue Guide — UK guidance on advertising and promotion of medicines, including prescription-only medicines.
ASA CAP advice on prescription-only medicines and websites — CAP advice on what may appear on clinic or pharmacy websites, including cautions on price lists.